Effectiveness of 13-valent pneumococcal conjugate vaccine on all-cause pneumonia in children under 5 years in Shanghai, China: An observational study
Authors:
Open Access
- 23 August 2023
- Vol. 41 (41) , 5979-5986
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Modeling the impact of the 7-valent pneumococcal conjugate vaccine in Chinese infants: an economic analysis of a compulsory vaccinationBMC Health Services Research, 2014
- Safety and immunogenicity of 13-valent pneumococcal conjugate vaccine in infants: A meta-analysisVaccine, 2013
- TRIVAC decision-support model for evaluating the cost-effectiveness of Haemophilus influenzae type b, pneumococcal and rotavirus vaccinationVaccine, 2013
- Economic evaluation of vaccination programme of 13-valent pneumococcal conjugate vaccine to the birth cohort in JapanVaccine, 2013
- The fundamental link between pneumococcal carriage and diseaseExpert Review of Vaccines, 2012
- Burden of Pneumonia and Meningitis Caused by Streptococcus pneumoniae in China among Children under 5 Years of Age: A Systematic Literature ReviewPLOS ONE, 2011
- Pneumococcal serotype distribution and antimicrobial resistance in Chinese children hospitalized for pneumoniaVaccine, 2011
- Clinical and economic burden of community-acquired pneumonia among adults in EuropeThorax, 2010
- Global status of Haemophilus influenzae type b and pneumococcal conjugate vaccines: evidence, policies, and introductionsCurrent Opinion in Infectious Diseases, 2010
- Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimatesThe Lancet, 2009